Item 7.01 Regulation FD Disclosure.
In accordance with Regulation FD, Marpai, Inc. ("the Company"), hereby furnishes
the Investor Presentation the Company will present to analysts and investors on
or after January 24, 2022. The slides are attached hereto as Exhibit 99.1 and
will be available on the Company's website at marpaihealth.com. The information
contained in the Investor Presentation is summary information that is intended
to be considered in the context of the Company's Securities and Exchange
Commission ("SEC") filings and other public announcements that the Company may
make, by press release or otherwise, from time to time. The presentation does
not provide information concerning the financial condition of the Company with
respect to the full fiscal year of 2021. To the extent that estimates, or
targets have been provided concerning 2021 or any subsequent years, these
reflect statements that have previously been made in the Company's securities
filings. The Company undertakes no duty or obligation to publicly update or
revise the information contained in this presentation, although it may do so
from time to time. Any such updating may be made through the filing of other
reports or documents with the SEC, through press releases or through other
public disclosure.
In accordance with General Instruction B.2 of Form 8-K, the information
furnished pursuant to Item 7.01, including Exhibits 99.1 furnished herewith,
shall not be deemed "filed" for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed
incorporated by reference in any filing under the Securities Act of 1933, as
amended, or the Exchange Act, except as shall be expressly set forth by specific
reference in such a filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number Description
99.1 Marpai Inc. Investor Presentation
Cover Page Interactive Data File (formatted as inline XBRL and
104 contained in Exhibit 101)
-2-
© Edgar Online, source Glimpses
MARPAI, INC. 
